petmed express inc. - PETS

PETS

Close Chg Chg %
1.81 -0.05 -2.76%

Closed Market

1.76

-0.05 (2.76%)

Volume: 64.17K

Last Updated:

Sep 8, 2026, 4:00 PM EDT

Company Overview: petmed express inc. - PETS

PETS Key Data

Open

$1.81

Day Range

1.74 - 1.81

52 Week Range

1.57 - 4.10

Market Cap

$39.24M

Shares Outstanding

21.68M

Public Float

14.59M

Beta

0.79

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.39

Yield

0.00%

Dividend

$0.30

EX-DIVIDEND DATE

Aug 11, 2023

SHORT INTEREST

N/A

AVERAGE VOLUME

103.19K

 

PETS Performance

1 Week
 
-2.76%
 
1 Month
 
-11.11%
 
3 Months
 
-4.86%
 
1 Year
 
-37.14%
 
5 Years
 
-93.79%
 

PETS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About petmed express inc. - PETS

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs, cats, and horses. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

PETS At a Glance

PetMed Express, Inc.
420 South Congress Avenue
Delray Beach, Florida 33445
Phone 1-561-526-4444 Revenue 179.02M
Industry Specialty Stores Net Income -57,286,000.00
Sector Retail Trade Employees 189
Fiscal Year-end 03 / 2027
View SEC Filings

PETS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.266
Price to Book Ratio 1.685
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.218
Enterprise Value to Sales 0.15
Total Debt to Enterprise Value 0.02

PETS Efficiency

Revenue/Employee 947,201.058
Income Per Employee -303,100.529
Receivables Turnover 93.827
Total Asset Turnover 1.557

PETS Liquidity

Current Ratio 0.837
Quick Ratio 0.576
Cash Ratio 0.412

PETS Profitability

Gross Margin 22.807
Operating Margin -17.548
Pretax Margin -32.04
Net Margin -32.00
Return on Assets -49.838
Return on Equity -100.437
Return on Total Capital -194.355
Return on Invested Capital -99.931

PETS Capital Structure

Total Debt to Total Equity 1.849
Total Debt to Total Capital 1.815
Total Debt to Total Assets 0.659
Long-Term Debt to Equity 0.145
Long-Term Debt to Total Capital 0.142
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Petmed Express Inc. - PETS

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
256.86M 281.06M 226.97M 179.02M
Sales Growth
-6.06% +9.42% -19.25% -21.13%
Cost of Goods Sold (COGS) incl D&A
189.39M 209.47M 164.87M 138.19M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.55M 7.06M 7.04M 9.39M
Depreciation
3.55M 5.06M 5.04M 7.39M
Amortization of Intangibles
- 2.00M 2.00M 2.00M
COGS Growth
-4.39% +10.60% -21.29% -16.18%
Gross Income
67.47M 71.59M 62.10M 40.83M
Gross Income Growth
-10.45% +6.11% -13.26% -34.25%
Gross Profit Margin
+26.27% +25.47% +27.36% +22.81%
2023 2024 2025 2026 5-year trend
SG&A Expense
68.90M 78.55M 60.73M 72.24M
Research & Development
- - - -
-
Other SG&A
68.90M 78.55M 60.73M 72.24M
SGA Growth
+38.83% +14.01% -22.69% +18.96%
Other Operating Expense
- - - -
-
Unusual Expense
- 1.20M 2.90M 27.26M
EBIT after Unusual Expense
(1.43M) (8.16M) (1.53M) (58.67M)
Non Operating Income/Expense
3.01M 1.89M 943.00K 1.31M
Non-Operating Interest Income
2.07M 511.00K 185.00K 511.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
1.58M (6.27M) (587.00K) (57.36M)
Pretax Income Growth
-94.15% -496.02% +90.64% -9,671.55%
Pretax Margin
+0.62% -2.23% -0.26% -32.04%
Income Tax
1.35M 1.19M 5.68M (73.00K)
Income Tax - Current - Domestic
2.92M 898.00K 436.00K 14.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.56M) 293.00K 5.25M (87.00K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
233.00K (7.46M) (6.27M) (57.29M)
Minority Interest Expense
- - - -
-
Net Income
233.00K (7.46M) (6.27M) (57.29M)
Net Income Growth
-98.90% -3,303.43% +15.98% -813.51%
Net Margin Growth
+0.09% -2.66% -2.76% -32.00%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
233.00K (7.46M) (6.27M) (57.29M)
Preferred Dividends
- - - -
-
Net Income Available to Common
233.00K (7.46M) (6.27M) (57.29M)
EPS (Basic)
0.0115 -0.366 -0.3045 -2.7382
EPS (Basic) Growth
-98.90% -3,282.61% +16.80% -799.24%
Basic Shares Outstanding
20.27M 20.40M 20.60M 20.92M
EPS (Diluted)
0.0115 -0.366 -0.3045 -2.7382
EPS (Diluted) Growth
-98.89% -3,282.61% +16.80% -799.24%
Diluted Shares Outstanding
20.34M 20.40M 20.60M 20.92M
EBITDA
2.12M 94.00K 8.41M (22.03M)
EBITDA Growth
-92.56% -95.56% +8,845.74% -361.96%
EBITDA Margin
+0.82% +0.03% +3.70% -12.30%

Snapshot

Average Recommendation SELL Average Target Price 2.15
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date N/A Current Year's Estimate N/A
Last Quarter’s Earnings -0.28 Median PE on CY Estimate N/A
Year Ago Earnings -2.74 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates N/A N/A N/A N/A
Mean Estimate N/A N/A N/A N/A
High Estimates N/A N/A N/A N/A
Low Estimate N/A N/A N/A N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Sell Sell Sell

Petmed Express Inc. in the News